In 2023, Casey McGlynn retired as a partner from Wilson Sonsini Goodrich & Rosati, where he had formed the life sciences practice in 1990 and grew it into one of the largest practices focused on medtech, healthtech, and biotech companies in the country today.

Casey formed, represented, sold, and took public many of the most important medical device companies founded over the span of 30 years leading up to his retirement.

He has extensive hands-on experience in helping entrepreneurs form, build, fund, and sell their companies. Casey formed, participated with the boards of, and invested in companies in all of the major medical device fields. He built close-working relationships with an unparalleled list of entrepreneurs, doctors, investors, engineers, and managers in this industry. Through his portfolio of companies, he met and negotiated with the leaders of all of the major medtech acquirers.

During much of his career, Casey also participated in forming and managing several small funds, all of which became top quartile performers. In 2005, he founded Life Science Angels (LSA), an angel organization focused on investing in medtech, healthtech, and biotech companies. Since its formation, LSA has invested over $50 million in more than 40 companies that have received an additional $600+ million in follow-on funding from VCs.